<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Data on <z:e sem="disease" ids="C0278704" disease_type="Neoplastic Process" abbrv="">childhood cancers</z:e> in Africa are sparse, particularly since the spread of HIV </plain></SENT>
<SENT sid="1" pm="."><plain>We aimed to document the frequency of <z:e sem="disease" ids="C0278704" disease_type="Neoplastic Process" abbrv="">pediatric cancers</z:e> presenting to a large central hospital in Malawi, detailing the presenting features, initial investigations, and HIV status of these children </plain></SENT>
<SENT sid="2" pm="."><plain>PROCEDURE: A retrospective audit of the spectrum and clinical presentation of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> among children (&lt;16 years) seen at Queen Elizabeth's Central Hospital (QECH), between 1998 and 2003 </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Seven hundred seven children with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> were seen, the number of cases per year increased over the time period; 50% (351) had Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, 13% (89) had <z:hpo ids='HP_0009919'>retinoblastoma</z:hpo>, and 9% (61) had Kaposi <z:hpo ids='HP_0100242'>sarcoma</z:hpo>, with a variety of other <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> comprising the remainder </plain></SENT>
<SENT sid="4" pm="."><plain>Kaposi <z:hpo ids='HP_0100242'>sarcoma</z:hpo> markedly increased in frequency over time </plain></SENT>
<SENT sid="5" pm="."><plain>Histological verification of diagnosis was available for 49% (348) </plain></SENT>
<SENT sid="6" pm="."><plain>The proportion of children with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> who were tested for HIV increased over time, but varied by <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> type </plain></SENT>
<SENT sid="7" pm="."><plain>Amongst those tested, the seroprevalence was 93% (52/56) for children with Kaposi <z:hpo ids='HP_0100242'>sarcoma</z:hpo>, 4% (11/289) for those with Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, 31% (8/26) for those with other non-Hodgkin <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, 7% (1/15) for those with <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin disease</z:e>, and 5% (5/103) for those with other <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: The number of cases seen per year has increased over the study period for almost <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, but in particular for Kaposi <z:hpo ids='HP_0100242'>sarcoma</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> remains the commonest <z:e sem="disease" ids="C1368871" disease_type="Neoplastic Process" abbrv="">pediatric tumor</z:e> in Malawi </plain></SENT>
<SENT sid="10" pm="."><plain>In the case of Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, and Kaposi <z:hpo ids='HP_0100242'>sarcoma</z:hpo> there is a significant difference in the presentation of HIV-seropositive and -seronegative children </plain></SENT>
</text></document>